See every side of every news story
Published loading...Updated

Is the DEA Sabotaging Psychedelic Research? Inside the Push to Schedule DOI and DOC

Summary by psychedelicstoday.com
In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris.  After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers studying serotonin […] The post Is the DEA Sabotaging…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

psychedelicstoday.com broke the news in on Tuesday, January 21, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.